Virtual Medicinal Product (VMP) - Erlotinib 25mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Erlotinib 25mg tablets | Start Date 15-06-2007 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01EB02
- BNF Codes
-
- BNF code 08010500
| Code | Start Date | End Date |
|---|---|---|
| 41763211000001102 | 09-05-2023 | |
| 414126009 | 21-06-2007 | 08-05-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Erlotinib hydrochloride | Based on Base Substance | Erlotinib | 25 mg |
Name
Erlotinib hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Erlotinib
Strength and UOM (Nmr)
25.0
Strength and UOM (Dmr)
Parent Products
-
VTMErlotinib
-
VMP(Current) Erlotinib 25mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |